Spastic Paraplegia Type 50
1 clinical trials · Condition
◉ Watch Spastic Paraplegia Type 50
| Record | Firm | Date |
|---|---|---|
| Administration of MELPIDA to Determine the Safety and Efficacy for Patients With Spastic Paraplegia Type 50 (NCT06069687) | The Hospital for Sick Children | 2022-03-11 |
Track Spastic Paraplegia Type 50 automatically
Every clearance here is in the API, with alerts when new ones post.